| Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis (NCT05118685) | Fayoum University | 2021-11-13 |
| A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects (NCT06033742) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-11-13 |
| Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470 (NCT05123820) | Idorsia Pharmaceuticals Ltd. | 2021-11-13 |
| A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC (NCT05236608) | National University Hospital, Singapore | 2021-11-12 |
| Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors (NCT05075993) | M.D. Anderson Cancer Center | 2021-11-12 |
| Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation (NCT05205863) | Prothya Biosolutions | 2021-11-12 |
| Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors (NCT05115344) | Guizhou Bailing Group Pharmaceutical Co Ltd | 2021-11-12 |
| A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer (NCT05080842) | Accutar Biotechnology Inc | 2021-11-12 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) (NCT05001373) | International AIDS Vaccine Initiative | 2021-11-12 |
| A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus (NCT05086445) | Eli Lilly and Company | 2021-11-12 |
| Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors (NCT05116709) | Bio-Thera Solutions | 2021-11-12 |
| Single-dose AQ001S PK Study in Healthy Volunteers (NCT05148312) | Aquilon Pharmaceuticals S.A. | 2021-11-12 |
| AZD9833 China PK Study (NCT04818632) | AstraZeneca | 2021-11-12 |
| Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults (NCT06033612) | Pfizer | 2021-11-12 |
| Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants (NCT05129475) | Pfizer | 2021-11-12 |
| IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC) (NCT05118334) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-11-12 |
| Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia (NCT05057221) | Lena Napolitano, MD | 2021-11-12 |
| Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma (NCT06021678) | Guangzhou Excelmab Inc. | 2021-11-12 |
| Mass Balance Study of NV-5138 in Healthy Male Subjects (NCT05384977) | Supernus Pharmaceuticals, Inc. | 2021-11-11 |
| Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers (NCT05227768) | Vigonvita Life Sciences | 2021-11-11 |
| Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 (NCT05088369) | Syneos Health | 2021-11-11 |
| A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants (NCT05042310) | Eli Lilly and Company | 2021-11-11 |
| Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC (NCT05158491) | JenKem Technology Co., Ltd. | 2021-11-11 |
| Study of NST-6179 in Healthy Subjects (NCT05181085) | NorthSea Therapeutics B.V. | 2021-11-11 |
| Mass Balance Study of NV-5138 in Healthy Male Subjects. (NCT05152680) | Navitor Pharmaceuticals, Inc. | 2021-11-11 |
| A Study of a New Vaccine Against Two Types of Ebola (NCT05079750) | University of Oxford | 2021-11-11 |
| PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray (NCT05122260) | Kenneth Palmer | 2021-11-11 |
| Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen (NCT04837196) | Astellas Pharma Global Development, Inc. | 2021-11-11 |
| A Study of LY3473329 in Healthy Japanese Participants (NCT05038787) | Eli Lilly and Company | 2021-11-11 |
| Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106 (NCT05054530) | Gmax Biopharm Australia Pty Ltd. | 2021-11-11 |
| Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects (NCT05158335) | MBX Biosciences | 2021-11-10 |
| Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV (NCT05205083) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-10 |
| Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. (NCT05176002) | Fujian Medical University Union Hospital | 2021-11-10 |
| A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis (NCT05014360) | Janssen Research & Development, LLC | 2021-11-10 |
| FT576 in Subjects With Multiple Myeloma (NCT05182073) | Fate Therapeutics | 2021-11-10 |
| Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder (NCT05271084) | Hawler Medical University | 2021-11-10 |
| Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac (NCT05205096) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-10 |
| Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function. (NCT05078580) | Novartis Pharmaceuticals | 2021-11-10 |
| A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment (NCT05112419) | AstraZeneca | 2021-11-10 |
| Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects (NCT05170763) | Anhui Palo Alto Pharmaceuticals, Inc. | 2021-11-10 |
| Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation (NCT04886206) | Nantes University Hospital | 2021-11-10 |
| A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013) | Cancer Research UK | 2021-11-10 |
| A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects (NCT05108350) | Shandong Suncadia Medicine Co., Ltd. | 2021-11-09 |
| Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study (NCT04827056) | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 2021-11-09 |
| Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function (NCT05032235) | Jiangsu HengRui Medicine Co., Ltd. | 2021-11-09 |
| A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091 (NCT05128591) | Addpharma Inc. | 2021-11-09 |
| Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors (NCT05207787) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-11-09 |
| Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer (NCT04982224) | Regeneron Pharmaceuticals | 2021-11-09 |
| A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers (NCT05328557) | Cugene Inc. | 2021-11-09 |
| QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors (NCT05108779) | Qilu Pharmaceutical Co., Ltd. | 2021-11-09 |
| A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation (NCT05119933) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2021-11-09 |
| Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at Altitude (NCT05036980) | Diffusion Pharmaceuticals Inc | 2021-11-09 |
| Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers (NCT05117554) | Arcus Biosciences, Inc. | 2021-11-09 |
| ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer (NCT06570031) | Ono Pharmaceutical Co., Ltd. | 2021-11-09 |
| Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients (NCT04539236) | Mikkael Sekeres, MD | 2021-11-09 |
| Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer (NCT04996771) | Sun Yat-sen University | 2021-11-09 |
| A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study (NCT05130437) | ModernaTX, Inc. | 2021-11-09 |
| A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function (NCT05094934) | Novo Nordisk A/S | 2021-11-09 |
| A Study of JNJ-75220795 in Japanese Participants (NCT05039710) | Janssen Pharmaceutical K.K. | 2021-11-08 |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors (NCT04851119) | Children's Oncology Group | 2021-11-08 |
| First in Human Study of CT-1500 in Healthy Participants (NCT05070702) | Circadian Therapeutics Ltd | 2021-11-08 |
| Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy (NCT05076838) | Neurelis, Inc. | 2021-11-08 |
| Phase I/II Clinical Trial of LBL-015 for Injection (NCT05107011) | Nanjing Leads Biolabs Co.,Ltd | 2021-11-08 |
| Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors (NCT05547906) | MetaFines | 2021-11-08 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 (NCT05105048) | ModernaTX, Inc. | 2021-11-08 |
| An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy Subjects (NCT05857449) | Luye Pharma Group Ltd. | 2021-11-08 |
| COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease (NCT05081388) | Regeneron Pharmaceuticals | 2021-11-08 |
| A Study of PF-07258669 In Healthy Adult Participants (NCT05113940) | Pfizer | 2021-11-08 |
| Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment (NCT05126472) | Memorial Sloan Kettering Cancer Center | 2021-11-08 |
| A Study of CDX-0159 in Patients With Prurigo Nodularis (NCT04944862) | Celldex Therapeutics | 2021-11-08 |
| Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State (NCT05098886) | Dong-A ST Co., Ltd. | 2021-11-07 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA (NCT05003934) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-11-07 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD (NCT05018845) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-11-06 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes (NCT05003908) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-11-06 |
| Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients (NCT06051565) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-06 |
| A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors (NCT05109975) | Debiopharm International SA | 2021-11-05 |
| A Study of NDI 1150-101 in Patients With Solid Tumors (NCT05128487) | Nimbus Saturn, Inc. | 2021-11-05 |
| Gene Transfer Clinical Trial for Krabbe Disease (NCT04693598) | Forge Biologics, Inc | 2021-11-05 |
| A First-in-Human Study of KINE-101 in Healthy Volunteers (NCT07343323) | Kine Sciences Co., Ltd. | 2021-11-05 |
| A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers (NCT05403281) | Dong Wha Pharmaceutical Co. Ltd. | 2021-11-05 |
| Enpatoran Human Mass Balance and Absolute Bioavailability Study (NCT05110027) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2021-11-05 |
| A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers (NCT05088421) | Bugworks Research Inc. | 2021-11-05 |
| A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer (NCT04827810) | Fox Chase Cancer Center | 2021-11-05 |
| Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation (NCT04535193) | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 2021-11-05 |
| A Multiple-Dose Study of LY3502970 in Healthy Participants (NCT05110794) | Eli Lilly and Company | 2021-11-05 |
| Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients (NCT05116826) | Genfit | 2021-11-05 |
| A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion (NCT05143463) | Neuracle Science Co., LTD. | 2021-11-04 |
| "CHANGE COVID-19 Severity" (NCT04941703) | Vanderbilt University Medical Center | 2021-11-04 |
| A Study of CBP-1018 in Patients With Advanced Solid Tumors (NCT04928612) | Coherent Biopharma (Suzhou) Co., Ltd. | 2021-11-04 |
| Evaluation of the Interactions of Cannabidiol (CBD) With Morphine (NCT05143424) | National Institute on Drug Abuse (NIDA) | 2021-11-04 |
| Natural Killer (NK) Cell Therapy for B-Cell Malignancies (NCT05379647) | Zhejiang University | 2021-11-04 |
| Gene Therapy for IGHMBP2-Related Diseases (NCT05152823) | Megan Waldrop | 2021-11-04 |
| A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis (NCT05083078) | Janssen Research & Development, LLC | 2021-11-04 |
| HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia (NCT04925661) | Sunshine Lake Pharma Co., Ltd. | 2021-11-04 |
| Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product (NCT05158192) | Laboratorios Andromaco S.A. | 2021-11-04 |
| Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (NCT05768321) | GenEros Biopharma Hangzhou Ltd | 2021-11-04 |
| A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck (NCT04830592) | Akamis Bio | 2021-11-04 |
| Pain Control Following Total Hip Arthroplasty (NCT05062356) | St. Mary's Research Center, Canada | 2021-11-04 |
| SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies (NCT04684108) | Hangzhou Sumgen Biotech Co., Ltd. | 2021-11-04 |
| Remote-delivered MBCT for SCAD Survivors (NCT04983680) | Massachusetts General Hospital | 2021-11-04 |